A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Part of paid clinical trials in Orange, California.

Sponsor
Alpha Cognition, Inc
Study ID
NCT07633470
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Zunveyl® — DRUG
    Zunveyl® delayed release oral tablets.

Study Details

The primary purpose of this study is to evaluate the safety and tolerability of Zunveyl® over 12 weeks of routine clinical use in adults with mild to moderate Alzheimer's disease.

Key Dates

First listed
Jun 8, 2026
Start date
May 20, 2026
Status verified
Aug 2026
Primary completion
Apr 30, 2027
Completion
Apr 30, 2027

Study Design

Enrollment
150 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Zunveyl®
    Participants will receive Zunveyl® at a dose of 5 milligrams (mg), delayed release tablets, orally, twice daily (BID) from Weeks 1 to 4, followed by 10 mg, delayed release tablets, orally, BID for the subsequent Weeks 5 to12.

Primary Outcome Measure

Number of Participants with Adverse Events (AEs) and Serious Adverse Events (SAEs) [ Time Frame: From Week 1 up to Week 12 ]

Central Contacts

Locations (14)

FacilityCityStateZIPSite coordinators
ATP Clinical Research, Inc - OrangeOrangeCalifornia92866
Gus Alva
[email protected]
949-354-5353
First Choice Neurology - Aventura Neurologic AssociatesAventuraFlorida33180
Jonathan Cross
[email protected]
303-933-5993
Galiz ResearchHialeahFlorida33016
Jose Gamez
[email protected]
305-820-3381
Clincloud, LLC - Viera OfficeMelbourneFlorida32940
Rosemary Laird
[email protected]
407-680-0534
Allied Biomedical Research Institute (ABRI), IncMiamiFlorida33155
Michael Pfeffer
[email protected]
305-643-8400
CCM Clinical Research Group, LLCMiamiFlorida33133
Francisco Ricart
[email protected]
305-285-0705
Progressive Medical ResearchPort OrangeFlorida32127
Richard Marshall
[email protected]
386-304-7070
Essential Concepts Research Solutions (ECRS)Palos HillsIllinois60465
Wayne Burrows
[email protected]
217-370-0518
NexGen ResearchFort WayneIndiana46804
Subhash Reddy
[email protected]
419-516-0954
Quest Research InstituteFarmington HillsMichigan48334
Aaron Ellenbogen
[email protected]
248-957-8940
Psympatica, LLCSt LouisMissouri63141
Arturo Taca
[email protected]
314-997-5208
Tekton Research Saint Louis PsychiatrySt LouisMissouri63128
Ernest Graypel, MD
[email protected]
314-525-5050
Alzheimer's Disease Research CenterAlbanyNew York12208
Richard Holub
[email protected]
319-426-0575
Neurology Clinic, P.C.CordovaTennessee38018
Thomas Arnold
[email protected]
901-866-9252

Find similar trials in Orange, CA

Nationwide
Alzheimer's disease trialsNeurology trialsDementia care trialsBrain disorders trialsGeriatrics trials
By condition
Alzheimer's disease
By specialty
NeurologyDementia careBrain disordersGeriatrics
By research site
ATP Clinical Research, Inc - Orange· Orange, CAFirst Choice Neurology - Aventura Neurologic Associates· Aventura, FLGaliz Research· Hialeah, FLClincloud, LLC - Viera Office· Melbourne, FLAllied Biomedical Research Institute (ABRI), Inc· Miami, FLCCM Clinical Research Group, LLC· Miami, FL

Related Studies